Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide Once Daily vs Twice Daily in HIV-1
NCT00089492Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2004
- Primary completion
- Jun 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Jul 2004; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00089492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089492.